It’s difficult to overstate the physical, emotional, and financial toll that cancer takes on people around the world. Cancer regularly figures among the leading causes of death worldwide, and rates are increasing globally-- predicted to rise from 18 million to 40 million cases per year over the next decade. Increased cell growth and proliferation, as well as decreased cell attrition, are classic hallmarks of cancer. Chemotherapy is a mainstay of cancer therapy, but its efficacy varies widely between cancers and the treatment as a whole is largely non-specific, susceptible to resistance, and laden with toxic side effects. There is a need for new treatment paradigms, especially those that can target a specific signaling pathway.